David Adlam, MD
Dr. Adlam is an interventional cardiologist and researcher in a busy metropolitan heart attack center. He completed his BMBCH, and DPhil at University of Oxford, and is a Member of the Royal College of Physicians. His research interests include spontaneous coronary artery dissection (SCAD); infective endocarditis; cardio-oncology; coronary optical coherence tomography (OCT), including its role in minimal invasive autopsy; and the role of tetrahydrobiopterin in the autonomic dysregulation of heart failure.
In 2010, Dr. Adlam first delved into the science of SCAD and published “Management of Spontaneous Coronary Artery Dissection in the Primary Percutaneous Coronary Intervention Era,” in the Journal of Invasive Cardiology. In 2013, in collaboration with a group of SCAD survivors in UK and Ireland, he launched and became clinical director of the SCAD UK/EU research initiative and the patient website portal hosted by the National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Unit (LCBRU). This initiative has been supported by the British Cardiovascular Society and the British Cardiovascular Intervention Society.
Under Dr. Adlam’s direction, the LCBRU was awarded a grant by the British Heart Foundation in January 2014, which allowed assignment of a dedicated research fellow to SCAD-related research. The LCBRU is one of 20 units throughout England funded by the NIHR, a strategic research funding body within the National Health Service (NHS). The LCBRU is a partnership between the University of Leicester and the University Hospitals of Leicester NHS Trust.